About this episode
The House Budget Committee advanced President Trump’s multi trillion-dollar domestic policy package Sunday night, just two days after conservatives voted to reject it. CNBC’s Eamon Javers reports on this and President Trump’s clash with Walmart over tariff-driven price hikes. Walter Isaacson, biographer and Tulane professor, discusses gene editing breakthroughs and biotech innovation amid federal funding cuts, as well as the White House’s relationship with corporate America’s leaders. Then, Business Roundtable CEO Josh Bolten weighs in on how CEOs are responding to Trump-era policies, including the President’s trade agenda. Plus, Regeneron Pharmaceuticals has announced plans to acquire most of 23andMe’s assets for $256 million. Walter Issacson 18:22 Josh Bolten 28:39 In this episode: Eamon Javers, @EamonJavers Walter Isaacson, @WalterIsaacson Becky Quick, @BeckyQuick Andrew Ross Sorkin, @andrewrsorkin Zach Vallese, @zachvallese Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.